🔗 Share this article

The prestigious award in Physiology or Medicine has been granted for revolutionary findings that illuminate how the immune system targets dangerous infections while sparing the healthy tissues.

Three esteemed scientists—from Japan Shimon Sakaguchi and US scientists Mary Brunkow and Dr. Ramsdell—received this accolade.

The work identified specialized "sentinels" within the immune system that remove malfunctioning immune cells capable of harming the body.

The findings are now paving the way for new treatments for immune disorders and malignancies.

These laureates will divide a prize fund valued at 11m Swedish kronor.

Crucial Findings

"The work has been essential for understanding how the body's defenses operates and the reason we do not all suffer from serious autoimmune diseases," stated the chair of the award panel.

This trio's research address a fundamental mystery: In what way does the immune system defend us from countless infections while keeping our healthy cells intact?

The immune system uses immune cells that scan for signs of infection, even pathogens and bacteria it has never encountered.

Such cells utilize sensors—called recognition units—that are generated randomly in a vast number of combinations.

This provides the immune system the ability to combat a wide array of threats, but the unpredictability of the mechanism unavoidably creates immune cells that can attack the host.

Security Guards of the Immune System

Researchers previously understood that a portion of these problematic defense cells were destroyed in the immune organ—the site where immune cells mature.

The latest award honors the discovery of T-reg cells—described as the immune system's "peacekeepers"—which travel through the body to disarm any defenders that assault the healthy cells.

We know that this process fails in autoimmune diseases such as juvenile diabetes, MS, and RA.

A prize committee stated, "The findings have established a new field of research and accelerated the creation of new therapies, for example for cancer and autoimmune diseases."

Regarding malignancies, regulatory T-cells prevent the body from fighting the growth, so research are focused on lowering their numbers.

For self-attack disorders, trials are exploring increasing regulatory T-cells so the body is no longer under attack. A comparable approach could also be effective in reducing the chances of transplanted organ failure.

Pioneering Experiments

Professor Sakaguchi, of Osaka University, performed experiments on rodents that had their thymus removed, leading to self-attack conditions.

The researcher showed that injecting immune cells from healthy animals could prevent the illness—implying there was a mechanism for blocking defenders from attacking the host.

Mary Brunkow, affiliated with the Institute for Systems Biology in a US city, and Fred Ramsdell, currently at Sonoma Biotherapeutics in San Francisco, were studying an inherited autoimmune disease in mice and humans that led to the identification of a genetic factor vital for how regulatory T-cells operate.

"Their pioneering work has uncovered how the body's defenses is controlled by T-reg cells, stopping it from mistakenly attacking the healthy cells," commented a prominent physiology specialist.

"This work is a striking illustration of how basic physiological research can have broad implications for human health."